Home » Stocks » ZY

Zymergen, Inc. (ZY)

Zymergen will go public soon, but the exact IPO date is still unknown.
Stock Price: Pending
IPO price not available yet
Market Cap n/a
Revenue (ttm) 13.28M
Net Income (ttm) -262.19M
Shares Out n/a
EPS (ttm) n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day n/a
Last Price n/a
Previous Close n/a
Change ($) n/a
Change (%) n/a
Day's Open n/a
Day's Range n/a
Day's Volume n/a
52-Week Range n/a

News

Hide News

Zymergen Inc, backed by SoftBank Group Corp Inc's Vision Fund, is looking to raise around $100 million through an initial public offering in the United States, according to a regulatory filing on T...

2 weeks ago - Reuters

Zymergen, Inc. has filed to go public with an IPO on the NASDAQ.

2 weeks ago - SEC

About ZY

Zymergen partners with Nature to design, develop, and commercialize bio-based breakthrough products that deliver extraordinary value to customers in a broad range of industries. Our first innovations include films designed for electronics companies to use in new categories of smart devices, including rollable tablets and naturally derived UV protection. We create new products with a proprietary platform that unlocks the design and manufacturing efficiency of biological processes with technology’s ability to rapidly iterate and control diverse... [Read more...]

Industry
Commercial Physical & Biological Research
IPO Date
Pending
CEO
Josh Hoffman
Employees
762
Stock Exchange
NASDAQ
Ticker Symbol
ZY
Full Company Profile

Financial Performance

In 2020, Zymergen's revenue was $13.28 million, a decrease of -13.85% compared to the previous year's $15.42 million. Losses were -$262.19 million, 10.7% more than in 2019.

Financial Statements